OncoImmunology
Volume 6, 2017 - Issue 7
Review
CEACAM1 as a multi-purpose target for cancer immunotherapy
Matthew DanknerGoodman Cancer Research Centre, McGill University, Montreal, QC, Canada
http://orcid.org/0000-0003-4869-5895
http://orcid.org/0000-0003-4869-5895, Scott D. Gray-OwenDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canadahttp://orcid.org/0000-0002-1477-3616
http://orcid.org/0000-0002-1477-3616, , Richard S. BlumbergDivision of Gastroenterology, Hepatology, and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USAhttp://orcid.org/0000-0002-9704-248x
http://orcid.org/0000-0002-9704-248x & Nicole BeaucheminGoodman Cancer Research Centre, McGill University, Montreal, QC, CanadaCorrespondence[email protected]
http://orcid.org/0000-0002-7445-8765
http://orcid.org/0000-0002-7445-8765